Enrico N De Toni

18PUBLICATIONS
89CO-AUTHORS
Molecular targetsInnate immunityHaematological tumoursMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 06, 2026
Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.

|Jun 25, 2026
RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma model.

|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI Registry.

|Oct 27, 2025
Treatment gaps and survival outcomes of hepatocellular carcinoma: insights from a nationwide, claims-based study.

Simone Schrodi, Karin Berger-Thürmel, Selina Becht

|Apr 04, 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal Cohort.

Najib Ben Khaled, Valentina Zarka, Bernard Hobeika

|Mar 28, 2025
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study.

Christian Möhring, Moritz Berger, Farsaneh Sadeghlar

Pageof 3

Frequent Collaborators

10 joint publications

Najib Ben Khaled

6 joint publications

Matthias Pinter

4 joint publications

Bernhard Scheiner

3 joint publications

Arndt Vogel